E-Folder - Internet and Businesses Online

According to Joseph Rago of the Wall Street Journal, if you are one who writes blogs, you are a fool. If that is not bad enough, if you read them, you a

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

re an imbecile. What would you rather be? Unfortunately, I guess I am both, because I am guilty of both. I find this interesting coming from a publicati

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

on that is still trying to sell content that people can get for free else where. Ideologically, I agree with the editorial pages of the Journal on most

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

economic and political issues, but they completely underestimate the power of the Web. Then again, virtually every traditional publication is guilty of

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

this short sightedness. Or is it wishful thinking, similar to what canal boat owners had about trains and trains had about planes (hoping the web is jus

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

t a fad)?

Rago paints with a broad brush, attacking blogs in general at will and his criticisms seem to cross ideological lines. He generally (and it a

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ppears, genuinely) dislikes blogs as a media, although the Wall Street Journal has blogs of their own. Rago is right, to a point, there certainly are nu

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

merous blogs that are not worth the space. This was pointed out very clearly in David A. Utter's piece at Webpronews.com (an excellent article). Rago's

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

basic premise is that the blogs are largely made up of unaccountable individuals, with insufficient skills, and significant axes to grind. This is a dan

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

gerous formula in the eyes of the media elite.

But is that not the case with all media? Some media is excellent and other sources are disastrous and th

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ere are many more that falls in between. Was there excellence and quality control in content when Dan Rather was involved in a fabricated story on the P

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

resident's military service record? Or was it responsible when CNN showed film footage of terrorists killing US troops? And each year there is list afte

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

r list of stories about irresponsible journalism made up of plagiarisms or even lies. I doubt anyone will soon forget the exploits of Jayson Blair, the

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

young man who devastated the credibility (with accusations against him of plagiarism and falsehoods) of one of the largest circulated and most respected

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

newspapers in the country, The New York Times. The point? All media -- institutional and popular -- are vulnerable to irresponsible behavior. No media,

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

including print, is in any position to look down its nose at others.

The difference is, most people take the institutional media quite seriously and p

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

opular media (such as blogs) with a grain of salt. Because of this, I actually believe blogs are "safer," since people often take the statements of inst

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

itutional media as "gospel." The reason it is easy to take pot shots at popular media is because there is so much of it and there are virtually no insti

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

tutional mechanisms to keep them accountable (for example, editors, lawyers, advertisers, etc.). The lesson I learn is that I need to be careful in what

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

I read and to weigh the credibility of the content and the writer very seriously. That is a lesson I learned long before I ever heard the word, "blog."

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-folder.org.ua/article/57988/e-folder-The-Great-Blog-Debate-Can-They-Be-Taken-Seriously.html">The Great Blog Debate: Can They Be Taken Seriously?</a>

BB link (for phorums):
[url=http://www.e-folder.org.ua/article/57988/e-folder-The-Great-Blog-Debate-Can-They-Be-Taken-Seriously.html]The Great Blog Debate: Can They Be Taken Seriously?[/url]

Too frequently, organizations and people want to rush to a solution and in doing so waste time, resources and the equity in their relationships by battling over solutions to different problems. “A problem half stated is a problem half solved.”

Positive attitude or negative attitudes are you and you are your attitudes. Lagging sales may be due to poor attitudes. What many business owners and sales people fail to realize is that their behaviors can create can't do attitudes in others.

If you're interested in getting involved with an affiliate marketing program you're probably wondering how it all works.

Tags

Links

E-Folder - The Great Blog Debate: Can They Be Taken Seriously?

Related Articles: